tradingkey.logo
tradingkey.logo
Search

Brightspring Health Services Inc

BTSG
Add to Watchlist
66.250USD
+1.820+2.82%
Close 06/18, 16:00ETQuotes delayed by 15 min
12.73BMarket Cap
43.56P/E TTM

Earnings Forecast

Currency: USD Updated: 2026-06-18
Previous score
8.75
Change
0
The current earnings forecast score of Brightspring Health Services Inc is 8.75, ranking 5 out of 76 in the Healthcare Providers & Services industry. The average price target is 40.00, with a high of 45.00 and a low of 38.00.

Analyst Rating

Based on 17 analysts
Buy
Current Rating
64.750
Target Price
-2.26%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

68
Total
8
Median
9
Average
Company name
Ratings
Analysts
Brightspring Health Services Inc
BTSG
17
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Natera Inc
NTRA
23
Tenet Healthcare Corp
THC
23
1
2
3
...
14

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

What is Brightspring Health Services Inc's expected revenue for the next quarter?

Brightspring Health Services Inc's expected revenue is 3.66B.

What is Brightspring Health Services Inc's price target?

Analysts forecast that Brightspring Health Services Inc's price target is USD 40.00, with the highest forecast at USD 45.00 and the lowest forecast at USD 38.00.

How have Brightspring Health Services IncBTSG's recent earnings per share performed?

The market expectation was USD 0.73, while Brightspring Health Services IncBTSG's earnings per share (EPS) for the previous quarter was USD 0.38. EPS for the next quarter is expected at USD 0.39.

What is the analyst rating for Brightspring Health Services Inc?

Based on the ratings of Brightspring Health Services Inc's stock from 17 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
KeyAI